AKAN
Akanda Corp.NASDAQHealthcare$0.69+4.35%ClosedMarket Cap: $100,217
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.09
P/S
0.29
EV/EBITDA
0.82
DCF Value
$-9.23
FCF Yield
-2408.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.3%
Operating Margin
-978.8%
Net Margin
-619.5%
ROE
-58.8%
ROA
-35.9%
ROIC
-95.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | -Infinity% | $-1.5M | $-815.0K | $-2.06 | — |
| Q4 2024 | $359.7K | 96.7% | $-2.0M | $-1.4M | $-1.09 | — |
| FY 2024 | $836.7K | 24.9% | $-4.4M | $-4.1M | $-3.93 | — |
| Q2 2024 | $477.0K | -29.2% | $-2.4M | $-2.7M | $-2.84 | — |
| Q4 2023 | $762.6K | -108.0% | $-4.2M | $-26.4M | $-228.20 | — |
| FY 2023 | $2.2M | 5.2% | $-10.1M | $-32.3M | $-60.91 | — |
| Q2 2023 | $1.4M | -197.9% | $-5.9M | $-5.9M | $-58.35 | — |
| Q4 2022 | $2.5M | -112.1% | $-10.4M | $-9.1M | $-104.67 | — |
| FY 2022 | $2.6M | 124.8% | $-20.2M | $-11.7M | $-841.40 | — |
| Q2 2022 | $73.1K | -10135.4% | $-11.0M | $-2.6M | $-35.90 | — |
| Q4 2021 | $24.1K | -2993.6% | $-2.6M | $-2.8M | $-40.35 | — |
| FY 2021 | $41.4K | -1725.1% | $-2.6M | $-8.1M | $-127.66 | — |